With the analysis among 7,352 patents, we discovered top 438 key players by total patent application. Genentech, Inc., Novartis AG, Smithkline Beckman Corp are dominant in this area. They take 7.44% of the total patent filing.
California, United States
Patent: 296
Basel-Stadt, Switzerland
Patent: 133
Pennsylvania, United States
Patent: 118
Massachusetts, United States
Patent: 91
Washington, United States
Patent: 75
F. Hoffmann-La Roche Ltd.
New York, United States
Patent: 62
Colorado, United States
Patent: 61
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 61
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 58
With the analysis among 259 patents, we discovered top 66 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Espervita Therapeutics, Inc., SERVIER PHARMA LLC are active in this area.
Institut National de la Santé et de la Recherche Médicale
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
Massachusetts, United States
Patent: 16
New South Wales, Australia
Patent: 13
California, United States
Patent: 13
Guangdong Sheng, China
Patent: 10
Beijing Shenrui Bolian Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Deverra Therapeutics, Inc.
Washington, United States
Patent: 9
New York, United States
Patent: 9
Kheiron Medical Technologies Ltd.
With the analysis among related 3,754 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., H. Lee Moffitt Cancer Center & Research Institute, Inc., Kite Pharma, Inc. take 3.57% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 51
H. Lee Moffitt Cancer Center & Research Institute, Inc.
California, United States
Patent: 41
Massachusetts, United States
Patent: 37
California, United States
Patent: 30
New York, United States
Patent: 30
Regents of the University of California
California, United States
Patent: 29
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 28
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 28
With the analysis among related 3,754 patents in last 5 years, we discover 275 new entrants. CRISPR Therapeutics AG, Immatics US, Inc., Lisen Imprinting Diagnostic Technology (Wuxi) Co., Ltd. are the most active new entrants in this area.
Massachusetts, United States
Patent: 37
Texas, United States
Patent: 22
Lisen Imprinting Diagnostic Technology (Wuxi) Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 20
West China Hospital of Sichuan University
Propella Therapeutics, Inc.
North Carolina, United States
Patent: 16
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 14
California, United States
Patent: 13
The Ninth People's Hospital of Shanghai Jiaotong University Medical College
undefined undefined
Patent: 13
With the analysis among 3,168 patents, we discovered top 262 universities and scientific research institutions by total patent application. The Johns Hopkins University, The Trustees of Columbia University in The City of New York, Baylor College of Medicine are dominant in this area. They take 8.18% of the total patent filing.
The Johns Hopkins University
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 54
Baylor College of Medicine
Texas, United States
Patent: 41
Washington, United States
Patent: 40
Massachusetts, United States
Patent: 38
North Carolina, United States
Patent: 33
University of South Florida
National University of Singapore
Central Region, Singapore
Patent: 28
Georgetown University School of Medicine
District of Columbia, United States
Patent: 27
Connecticut, United States
Patent: 26